Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,740 GBX | -1.94% | -0.91% | +19.98% |
May. 28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.98% | 92.44B | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- LBBW Raises GSK PT, Reiterates Buy Rating